A Study of LY2875358 in Participants With Advanced Cancer

Clinical trial NCT01287546 · COMPLETED

Trial details

NCT number: NCT01287546
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2010-04-13
Primary completion: 2015-01-08
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.